Ignacio Molina-Leyva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ignacio Molina-Leyva has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Molina-Leyva
Dermatology Department Hospital Universitario Virgen de las Nieves‐Ibs. Granada Granada Spain
4 shared publications Ana Almodovar-Real
Department of Dermatology, Hospital Santa Ana, Granada, Spain
2 shared publications- Aurora Bueno-Cavanillas
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain
2 shared publications - José Juan Jiménez-Moleón
Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, Granada 18016, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada 18012, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid 28029, Spain
2 shared publications Ramon Naranjo-Sintes
Department of Dermatology, Complejo Hospitalario Universitario Granada, Avenida Doctor Oloriz 16, 18012, Granada, Spain
2 shared publications- Blanca Riquelme-Gallego
Department of Preventive Medicine and Public Health, University of Granada, 18016 Granada, Spain
1 shared publication
Latest Publications
- Open Access
Effectiveness of Mediterranean Diet Implementation in Dry Eye Parameters: A Study of PREDIMED-PLUS Trial
The purpose of this study is to evaluate the effect of a Mediterranean diet supplemented with extra virgin olive oil and nuts on dry eye parameters. The participants in this study were randomized into one of the two interventional arms: (1) a standard intervention group, a Mediterranean diet supplemented with extra virgin olive oil and nuts; and (2) an intensive intervention group, based on a hypocaloric Mediterranean diet and an intensive lifestyle program with physical activity and weight-loss goals. In both groups, common dry eye tests were conducted at baseline and after six months: the Ocular Surface Disease Index (OSDI), the Dry Eye Scoring System (DESS), tear break-up time (TBUT), the Schirmer’s test, and the Oxford staining grade. Sixty-seven eyes were examined. After six months, dry eye parameters improved in both groups; differences between groups were favorable for the intensive intervention group. The implementation of a Mediterranean diet pattern was beneficial for the selected patients with dry eye, and could be beneficial for patients with dry eye in general. Behavioral support for diet adherence and the promotion of healthy lifestyles (exercise) and weight loss (calorie restriction) have an added positive effect.
Open AccessEffectiveness of Mediterranean Diet Implementation in Dry Eye Parameters: A Study of PREDIMED-PLUS Trial
The purpose of this study is to evaluate the effect of a Mediterranean diet supplemented with extra virgin olive oil and nuts on dry eye parameters. The participants in this study were randomized into one of the two interventional arms: (1) a standard intervention group, a Mediterranean diet supplemented with extra virgin olive oil and nuts; and (2) an intensive intervention group, based on a hypocaloric Mediterranean diet and an intensive lifestyle program with physical activity and weight-loss goals. In both groups, common dry eye tests were conducted at baseline and after six months: the Ocular Surface Disease Index (OSDI), the Dry Eye Scoring System (DESS), tear break-up time (TBUT), the Schirmer’s test, and the Oxford staining grade. Sixty-seven eyes were examined. After six months, dry eye parameters improved in both groups; differences between groups were favorable for the intensive intervention group. The implementation of a Mediterranean diet pattern was beneficial for the selected patients with dry eye, and could be beneficial for patients with dry eye in general. Behavioral support for diet adherence and the promotion of healthy lifestyles (exercise) and weight loss (calorie restriction) have an added positive effect.
- 1 July 2018
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 93 (7) , 350-353
Actualización sobre el manejo del tumor vasoproliferativo
- 1 July 2018
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 93 (7) , 350-353
Actualización sobre el manejo del tumor vasoproliferativo
- 30 March 2017
- Published by Wiley in Acta Ophthalmologica
- Vol. 95 (8) , e677-e685
Efficacy of nutritional supplementation with omega‐3 and omega‐6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials
Purpose: To critically appraise scientific evidence regarding the efficacy of nutritional supplementation with omega‐3 and omega‐6 fatty acids for the treatment of dry eye syndrome (DES).Methods: A systematic review of randomized clinical trials was performed. Two independent reviewers selected and analysed the scientific papers that met inclusion and exclusion criteria. Objective and subjective efficacy outcomes were assessed.Results: The trials involved a total of 2591 patients in fifteen independent studies. All studies were published between 2005 and 2015. The supplements used were mostly omega‐3 and omega‐6 in different proportions. Subjective improvement was measured using mainly Ocular Surface Disease Index (OSDI) test and Dry Eye Severity Score (DESS) test: significant differences in favour of the experimental group were found in seven of the studies. The objective amelioration was assessed by lacrimal function parameters: Tear break‐up time (TBUT) significantly increased in nine studies and Schirmer's test in four studies.Conclusion: We observed a discrete improvement in the parameters of tear function. Scientific evidence is not strong enough to systematically recommend the use of omega‐3 and omega‐6 fatty acids as a standalone treatment of DES independently from its aetiology. However, they could be considered as an effective alternative to topical treatment in patients with DES secondary to certain pathologies.
- 30 March 2017
- Published by Wiley in Acta Ophthalmologica
- Vol. 95 (8) , e677-e685
Efficacy of nutritional supplementation with omega‐3 and omega‐6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials
Purpose: To critically appraise scientific evidence regarding the efficacy of nutritional supplementation with omega‐3 and omega‐6 fatty acids for the treatment of dry eye syndrome (DES).Methods: A systematic review of randomized clinical trials was performed. Two independent reviewers selected and analysed the scientific papers that met inclusion and exclusion criteria. Objective and subjective efficacy outcomes were assessed.Results: The trials involved a total of 2591 patients in fifteen independent studies. All studies were published between 2005 and 2015. The supplements used were mostly omega‐3 and omega‐6 in different proportions. Subjective improvement was measured using mainly Ocular Surface Disease Index (OSDI) test and Dry Eye Severity Score (DESS) test: significant differences in favour of the experimental group were found in seven of the studies. The objective amelioration was assessed by lacrimal function parameters: Tear break‐up time (TBUT) significantly increased in nine studies and Schirmer's test in four studies.Conclusion: We observed a discrete improvement in the parameters of tear function. Scientific evidence is not strong enough to systematically recommend the use of omega‐3 and omega‐6 fatty acids as a standalone treatment of DES independently from its aetiology. However, they could be considered as an effective alternative to topical treatment in patients with DES secondary to certain pathologies.
- 7 June 2016
- Published by Springer Nature in Archives of Sexual Behavior
- Vol. 45 (8) , 2047-2055
Prevalence and Associated Factors of Erectile Dysfunction in Patients With Moderate to Severe Psoriasis and Healthy Population: A Comparative Study Considering Physical and Psychological Factors
Recent studies have shown that psoriasis is associated with an increased prevalence of erectile dysfunction. To our knowledge, no comparative study has considered simultaneously the role of organic factors and psychological factors in this process. We performed a prospective case series study matched by age to explore the prevalence of erectile dysfunction in psoriasis patients compared to a healthy population and to investigate the role of anxiety, depression, and cardiovascular risk factors in the relationship between psoriasis and erectile dysfunction. The healthy group was matched by frequency to cases by age. Seventy-nine patients with moderate to severe psoriasis and 79 healthy controls participated in the study. Participants completed the Massachusetts General Hospital Sexual Functioning Questionnaire and the Hospital Anxiety and Depression Scale. Psoriasis patients had an increased prevalence of erectile dysfunction in comparison to controls, 34.2 vs. 17.7 % (p < .05). Multivariate analysis showed a significant association between erectile dysfunction and age, smoking and anxiety/depression, but not with psoriasis per se. In conclusion, the higher prevalence of smoking and anxiety/depression among patients with moderate to severe psoriasis probably explains the higher prevalence of erectile dysfunction in this population.
- 7 June 2016
- Published by Springer Nature in Archives of Sexual Behavior
- Vol. 45 (8) , 2047-2055
Prevalence and Associated Factors of Erectile Dysfunction in Patients With Moderate to Severe Psoriasis and Healthy Population: A Comparative Study Considering Physical and Psychological Factors
Recent studies have shown that psoriasis is associated with an increased prevalence of erectile dysfunction. To our knowledge, no comparative study has considered simultaneously the role of organic factors and psychological factors in this process. We performed a prospective case series study matched by age to explore the prevalence of erectile dysfunction in psoriasis patients compared to a healthy population and to investigate the role of anxiety, depression, and cardiovascular risk factors in the relationship between psoriasis and erectile dysfunction. The healthy group was matched by frequency to cases by age. Seventy-nine patients with moderate to severe psoriasis and 79 healthy controls participated in the study. Participants completed the Massachusetts General Hospital Sexual Functioning Questionnaire and the Hospital Anxiety and Depression Scale. Psoriasis patients had an increased prevalence of erectile dysfunction in comparison to controls, 34.2 vs. 17.7 % (p < .05). Multivariate analysis showed a significant association between erectile dysfunction and age, smoking and anxiety/depression, but not with psoriasis per se. In conclusion, the higher prevalence of smoking and anxiety/depression among patients with moderate to severe psoriasis probably explains the higher prevalence of erectile dysfunction in this population.
- Open Access
- 1 June 2015
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 90 (3) , 338-345
Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
Key words: Anxiety; Case-control studies; Depression; Psoriasis; Sexual dysfunctions, psychological
- 1 June 2015
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 90 (3) , 338-345
Open AccessDistribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
Key words: Anxiety; Case-control studies; Depression; Psoriasis; Sexual dysfunctions, psychological